Literature DB >> 11238875

Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes.

K A Robertson1, E J Usherwood, A A Nash.   

Abstract

Murine gammaherpesvirus 68-infected S11 cells were injected subcutaneously into nude mice. Adoptively transferred restimulated lymphocytes consistently elicited the regression of S11 tumors. CD4 T lymphocytes were most effective in preventing tumor formation, and immunohistochemistry highlighted populations of CD4 T cells in regressing tumors.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11238875      PMCID： PMC114142          DOI： 10.1128/JVI.75.7.3480-3482.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  9 in total

Review 1.  Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8)--a new human tumour virus.

Authors:  L A Brooks; A J Wilson; T Crook
Journal:  J Pathol       Date:  1997-07       Impact factor: 7.996

2.  Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma.

Authors:  P Biberfeld; B Ensoli; M Stürzl; T F Schulz
Journal:  Curr Opin Infect Dis       Date:  1998-04       Impact factor: 4.915

Review 3.  Kaposi's sarcoma and human herpesvirus-8.

Authors:  R M Greenblatt
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

4.  Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice.

Authors:  E J Usherwood; J P Stewart; A A Nash
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Kinetic analysis of the specific host response to a murine gammaherpesvirus.

Authors:  P G Stevenson; P C Doherty
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes.

Authors:  S M Husain; E J Usherwood; H Dyson; C Coleclough; M A Coppola; D L Woodland; M A Blackman; J P Stewart; J T Sample
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.

Authors:  N P Sunil-Chandra; J Arno; J Fazakerley; A A Nash
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

8.  Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.

Authors:  J Wolf; A Draube; H Bohlen; A Jox; S Mücke; M Pawlita; P Möller; V Diehl
Journal:  Int J Cancer       Date:  1995-02-08       Impact factor: 7.396

9.  Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.

Authors:  J F Lacerda; M Ladanyi; D C Louie; J M Fernandez; E B Papadopoulos; R J O'Reilly
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307
  9 in total
  13 in total

Review 1.  The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders.

Authors:  Anna Merlo; Riccardo Turrini; Riccardo Dolcetti; Debora Martorelli; Elena Muraro; Patrizia Comoli; Antonio Rosato
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

Review 2.  Autophagy in innate and adaptive immunity against intracellular pathogens.

Authors:  Dorothee Schmid; Jörn Dengjel; Oliver Schoor; Stefan Stevanovic; Christian Münz
Journal:  J Mol Med (Berl)       Date:  2006-01-28       Impact factor: 4.599

3.  CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Authors:  Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

4.  Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.

Authors:  Kathleen A Stuller; Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

5.  CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth.

Authors:  Xiaozhan Liang; Rebecca L Crepeau; Weijun Zhang; Samuel H Speck; Edward J Usherwood
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.

Authors:  Katharina Schmidt; Effi Wies; Frank Neipel
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

7.  Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice.

Authors:  Vera L Tarakanova; Felipe Suarez; Scott A Tibbetts; Meagan A Jacoby; Karen E Weck; Jay L Hess; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  CD4 T cells specific for a latency-associated γ-herpesvirus epitope are polyfunctional and cytotoxic.

Authors:  Michael L Freeman; Claire E Burkum; Tres Cookenham; Alan D Roberts; Kathleen G Lanzer; Gail E Huston; Meghan K Jensen; John Sidney; Bjoern Peters; Jacob E Kohlmeier; David L Woodland; Linda F van Dyk; Alessandro Sette; Marcia A Blackman
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

Review 9.  CD4 CTL: living up to the challenge.

Authors:  Hilde Cheroutre; Mohammad Mushtaq Husain
Journal:  Semin Immunol       Date:  2013-11-15       Impact factor: 11.130

Review 10.  Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.

Authors:  Jianmin Zuo; Martin Rowe
Journal:  Viruses       Date:  2012-08-22       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.